We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

28 hedge funds and large institutions have $75.6M invested in Minerva Neurosciences in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

233% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 3

37% more capital invested

Capital invested by funds: $55.1M → $75.6M (+$20.5M)

33% more funds holding

Funds holding: 21 → 28 (+7)

Holders
28
Holders Change
+7
Holders Change %
+33.33%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
10
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$13M
2
CAM
Cormorant Asset Management
Massachusetts
+$3.24M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.26M
4
DADC
D.A. Davidson & Co
Montana
+$287K
5
UBS Group
UBS Group
Switzerland
+$242K

Top Sellers

Rank Fund Capital Flow
1
HCMT
Highland Capital Management (Texas)
Texas
-$2.31M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$97K
3
Creative Planning
Creative Planning
Kansas
-$2K
4
TRCT
Tower Research Capital (TRC)
New York
-$854
5
Citigroup
Citigroup
New York
-$43
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$31.1M +$13M +303,951 +93%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$17M – – –
CAM
3
Cormorant Asset Management
Massachusetts
$10.8M +$3.24M +75,988 +53%
HCMT
4
Highland Capital Management (Texas)
Texas
$5.46M -$2.31M -54,211 -33%
PA
5
Perceptive Advisors
New York
$4.98M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$3.2M +$2.26M +52,837 +431%
DADC
7
D.A. Davidson & Co
Montana
$819K +$287K +6,725 +68%
BCM
8
Bridgeway Capital Management
Texas
$559K +$107K +2,500 +28%
UBS Group
9
UBS Group
Switzerland
$290K +$242K +5,658 +2,397%
Goldman Sachs
10
Goldman Sachs
New York
$275K +$66.1K +1,547 +38%
NC
11
Nexthera Capital
New York
$209K – – –
Renaissance Technologies
12
Renaissance Technologies
New York
$181K +$157K +3,675 New
BFA
13
BlackRock Fund Advisors
California
$159K +$5.17K +121 +4%
Millennium Management
14
Millennium Management
New York
$148K +$129K +3,020 New
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$126K +$110K +2,567 New
SCM
16
Segantii Capital Management
Hong Kong
$110K +$98.3K +2,303 New
Morgan Stanley
17
Morgan Stanley
New York
$106K +$83.7K +1,961 +995%
Deutsche Bank
18
Deutsche Bank
Germany
$62K +$54.2K +1,269 New
SCM
19
Sterling Capital Management
North Carolina
$61K – – –
Citigroup
20
Citigroup
New York
$31K -$43 -1 -0.2%
BIM
21
BlackRock Investment Management
Delaware
$14K – – –
BA
22
BlackRock Advisors
Delaware
$12K – – –
Manulife (Manufacturers Life Insurance)
23
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$7K +$6.19K +145 New
Walleye Trading
24
Walleye Trading
New York
$7K +$6.41K +150 New
Bank of America
25
Bank of America
North Carolina
$5K +$4.23K +99 New
1
2

NERV Hedge Fund Activity: Q1 2016 in Review

28 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2016, worth a combined $75.6M — up 37% from $55.1M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new NERV positions and 2 closed out — a net gain of 7 holders — while 10 added to existing stakes and 3 trimmed.

The largest buyer was Federated Hermes, adding an estimated $13M. The largest seller was Highland Capital Management (Texas), cutting an estimated $2.31M.

  • 28 institutional investors held Minerva Neurosciences (NERV) as of Q1 2016, up from 21 in Q4 2015.
  • Funds reported $75.6M of Minerva Neurosciences stock for Q1 2016, up 37% quarter-over-quarter.
  • 9 funds opened new Minerva Neurosciences positions in Q1 2016 and 2 closed out, a net change of +7 holders.
  • The largest Minerva Neurosciences buyer in Q1 2016 was Federated Hermes, an estimated $13M added.
  • The largest Minerva Neurosciences seller in Q1 2016 was Highland Capital Management (Texas), an estimated $2.31M sold.

Based on aggregated 13F filings for Q1 2016.